Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Seiya Yamayoshi

机构:Tokyo University of Science, Tokyo Health Care University, National Institute of Infectious Diseases, National Center for Global Health and Medicine, The University of Tokyo · ORCID:0000-0001-7768-5157

发表论文 177 篇 · 总被引 9638 次 · h-index 44

代表论文

  • Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus (2025 · Communications Medicine · 被引 15)
  • Efficacy of baloxavir marboxil against bovine H5N1 virus in mice (2025 · Nature Communications · 被引 13)
  • Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3 (2025 · Nature Communications · 被引 11)
  • Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case (2024 · EBioMedicine · 被引 11)
  • An orally available P1′-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier (2024 · PNAS Nexus · 被引 10)
  • Structural basis of broad protection against influenza virus by a human antibody targeting the neuraminidase active site via a recurring motif in CDR H3 (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)